BAT Science

Quick Navigation

Jump to content Logo
 
Building
A Better
Tomorrow™
Our purpose is to build A Better Tomorrow™ by reducing the health impact of our business through offering a choice of less risky* products for our consumers. Science and innovation are accelerating our Tobacco Harm Reduction mission.
 
Research
We operate in a broad spectrum of scientific fields including molecular biology, toxicology and chemistry, and it is that breadth of expertise which fuels the relentless innovation and learning that sets us apart as an industry leader.
 
Vaccine development
COVID-19
We are working on a potential vaccine for COVID-19
Publications
  • A survey of aerosol exposure systems relative to the analysis of cytotoxicity: A Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA) perspective
    David Thorne
    November 2021
    A survey of aerosol exposure systems relative to the analysis of cytotoxicity: A Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA) perspective
  • Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial
    Tobacco Heating Products
    Nathan Gale
    July 2021
    Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial
  • A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation
    Vapour & THP
    Michael McEwan
    May 2021
    A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation

 
Insights
  • Meet our scientists
    Behind the Microscope
    Meet our scientists
  • Take a look at our latest press releases
    News & Features
    Take a look at our latest press releases
  • Find out more about our open and transparent approach
    Science Engagement
    Find out more about our open and transparent approach
  • Dr David O'Reilly shares his thoughts on science, COVID-19, and harm reduction
    Director's View
    Dr David O'Reilly shares his thoughts on science, COVID-19, and harm reduction
  • Explore our Quarterly Science Update
    Report
    Explore our Quarterly Science Update
  • Read our latest Science & Innovation Report
    Report
    Read our latest Science & Innovation Report
/
 
*Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.

Our products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.

max
xlarge
large
medium
small
mobile